ORIC
ORIC Pharmaceuticals Inc

827
Mkt Cap
$982.66M
Volume
18.00
52W High
$14.93
52W Low
$3.90
PE Ratio
-5.83
ORIC Fundamentals
Price
$10.09
Prev Close
$9.99
Open
$10.00
50D MA
$9.94
Beta
1.63
Avg. Volume
1.85M
EPS (Annual)
-$1.83
P/B
2.41
Rev/Employee
$0.00
$316.10
Loading...
Loading...
News
all
press releases
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Get Free Report) have earned a consensus rating of "Moderate Buy" from the fourteen analysts that are covering the firm, MarketBeat reports. One...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Oric Pharmaceuticals Highlights 2025 Milestones at Guggenheim, Targets Phase 3 Prostate Trial in 1H25
Oric Pharmaceuticals (NASDAQ:ORIC) used a fireside chat at the Guggenheim Biotech Conference to outline development priorities for its two lead oncology programs and to reiterate its expected 2025...
MarketBeat·4d ago
News Placeholder
Oric Pharmaceuticals (ORIC) Projected to Post Quarterly Earnings on Tuesday
Oric Pharmaceuticals (NASDAQ:ORIC) will be releasing its Q4 2025 earnings before the market opens on Tuesday, February 17. (View Earnings Report at...
MarketBeat·8d ago
News Placeholder
Oric Pharmaceuticals (NASDAQ:ORIC) Shares Down 6.8% - Time to Sell?
Oric Pharmaceuticals (NASDAQ:ORIC) Shares Down 6.8% - Here's Why...
MarketBeat·21d ago
News Placeholder
Oric Pharmaceuticals (NASDAQ:ORIC) Sees Large Volume Increase - What's Next?
Oric Pharmaceuticals (NASDAQ:ORIC) Sees Strong Trading Volume - Should You Buy...
MarketBeat·23d ago
News Placeholder
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Average Rating of "Moderate Buy" from Analysts
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Get Free Report) has received a consensus rating of "Moderate Buy" from the fourteen brokerages that are currently covering the stock, Marketbeat.com...
MarketBeat·27d ago
News Placeholder
Short Interest in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Grows By 19.6%
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Get Free Report) saw a large growth in short interest during the month of December. As of December 31st, there was short interest totaling 21,469,843 shares...
MarketBeat·30d ago
News Placeholder
Oric Pharmaceuticals (NASDAQ:ORIC) Sees Large Volume Increase - Still a Buy?
Oric Pharmaceuticals (NASDAQ:ORIC) Sees Strong Trading Volume - Still a Buy...
MarketBeat·1mo ago
News Placeholder
Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff
Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff PR Newswire VANCOUVER, BC, Jan...
PR Newswire·1mo ago
News Placeholder
Wedbush Reaffirms Outperform Rating for Oric Pharmaceuticals (NASDAQ:ORIC)
Wedbush reaffirmed an "outperform" rating and set a $20.00 price target on shares of Oric Pharmaceuticals in a research note on Tuesday...
MarketBeat·1mo ago
<
1
2
...
>

Latest ORIC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.